- Bernelli Zazzera A., Clerici C., “Patologia chimica del sistema nervoso
centrale”, Casa Ed. Ambrosiana, Milano, 1963
- Brex PA, Miszkiel KA, O’Riordan JI, Plant GT, Moseley IF, Thompson AJ et
al. “Assessing the risk of early multiple sclerosis in patients with clinically
isolated syndromes: the role of a follow up MRI”, J Neurol Neurosurg Psychiatry,
70(3): 390-393, 2001.
- Caroni P, Schwab M.E., “Antibody against myelin-associated inhibitor of
neurite growth neutralizes nonpermissive substrate properties of CNS white
matter”, Neuron, 1:85-96, 1988
- A.L. Kolodkin, “Le semaforine e le basi molecolari della repulsione alla
guida dei coni neuronali di accrescimento” Atti del 2° Congr. Intermaz. La
genetica e le Neuroscienze, Terni, luglio 2000, Fondaz. Agarini.
- Cowan W.M., Jessel T.M, Zipursky S.L., “Molecular and cellular Approaches
to Neural Development”, Oxford University Press, New York, 1997
- Cunningham B.A., Hemperly J.J., Murray B.A., Prediger E.A., Brackenbury
R. Edelman G.M., “Neural cell adhesion molecule: structure, immunoglobulin-like
domains, cell surface modulation and alternative RNA splicing”, Science, 236:799-806,
1987
- Davies R.W, Morris B.J. “Molecular Biology of the Neuron”, Bios Scientific
Publishers, Information Press Ltd, Oxford, U.K., 1997
- Dhib-Jalbut S., McFarlin D.E., “Immunology of Multiple sclerosis”, Ann.
Allergy, 64:433-444, 1990
- Filippi M. “La risonanza magnetica nello studio della sclerosi multipla”,
Sclerosi Multipla, Attività e prospettive, Masson ed., Milano, 2001
- Freddi A. “Moderne risorse nella riabilitazione del neuroleso”, Atti del
X Congr. Naz. So.M.I.Par., Bari, 27-29 sett. 2001. -Gasperini C., “Nuove prospettive
terapeutiche nella S.M.”, SM Italia, Ed. AISM, 2:3-8, 2000.
- Gerzeli S., “I costi della SM in Italia”, SM Italia, Ed AISM, 2:11-14, 2000
- Goodman C.S., “Mechanisms and molecules that control growth cone guidance”,
Annu. Rev. Neuros., 9:341-377, 1996
- Griffin J. “Experimental gene therapy and coriticospinal tract regeneration
after spinal cord transection”, Atti del II Congresso Internazionale “La genetica
nelle neuroscienze”, Terni, 2-5 luglio 2000, Promodis Ed., Brescia, 2000
- Gundersen R.W., “Response of sensory neurites and growth cones to patterned
substrata of laminin and fibronectin in vitro”, Dev. Biol., 121:423-431, 1987
- Harrison R.G., “The outgrowth of the nerve fiber as a mode of protoplasmatic
movement”, J.Exp:Zool, :787-846,1910
- Honmou, O., Felts, P.A., Waxman, S.G., and Kocsis, J.D.,“Restoration of
normal conduction properties in demyelinated spinal cord axons in the adult
rat by transplantation of exogenous Schwann cells". Journal of Neuroscience,
16:3199-3208, 1996.
- Imaizumi, T., Lankford, K.L., Waxman, S.G., Greer, C.A., Kocsis, J.D.“Transplanted
olfactory ensheathing cells remyelinate and enhance axonal conduction in the
demyelinated dorsal columns of the rat spinal cord. Journal of Neuroscience,
18(16): 6176-6185, 1998
- Imaizumi, T., Lankford, K.L., Kocsis, J.D.(2000) Transplantation of olfactory
ensheathing or Schwann cells restores rapid and secure conduction across the
transected spinal cord. Brain Research, 2000
- Kocsis, J.D., Waxman, S.G. Transplantation of myelin-forming cells into
the spinal cord:restoration of normal conduction in previously demyelinated
axons. Glial Cells and Behavior, P. Laming (Ed.), Cambridge University Press.
pp 181-198, 1998
- Kocsis, J.D.,“Restoration of function by glial cell transplantation into
demyelinated spinal cord”. Journal of Neurotrauma, 16(9): 695-703, 1999.
- Kurtzke J. F. “Rating neurological impairment in multiple sclerosis: an
expanded disability status scale“, Neurology, 33: 1444-1452, 1983.
- Lankford, K.L., Waxman, S.G. and Kocsis, J.D., Mechanisms of enhancement
of neurite regeneration:rat DRG neurite arborization in vitro after a conditioning
sciatic nerve lesion in vivo. Journal of Comparative Neurology, 391:11-29,
1998
- Lemmon V., Burden S.M., Payne H.R., Elmslie G.J., Hlavin M.L. “Neurite growth
on different substrates: permissive versus instructive influences and the
role of adhesive strenght”, J. Neurosc. 12:818-826, 1992
- Lublin F, Reingold S.C. et al., “Defining the clinical course of multiple
sclerosis: results of an international survey” , Neurology, 46:907-911, 1996.
- Mc Donald W.I., Compston A., Edan G. et al.: Recommended diagnostic criteria
for multiple sclerosis: guidelines from the International Panel on the Diagnosis
of Multiple Sclerosis, Ann. Neurol., 49 (6), 2001.
- Noronha A., Toscas A., Jensen M.A., “Interferon beta augments suppressor
cell function in multiple sclerosis”, Ann. Neurol., 27:207-210, 1990
- Oakley R.A., Tosney K.W., “Contact mediated mechanism of motor axon segmentation”,
J. Neuroscience, 13:3773-3792, 1993 - Panitch H.S., “Interferons in multiple
sclerosis: a review of the evidence”, Drugs, 44:946-962, 1992
- Poser C.M., Paty D.W., Scheimberg L.C. et al.,“New diagnostic criteria for
multiple sclerosis: guidelines for research protocols”, Ann. Neurol. 13:227-231,
1983
- Raper J.A., Bastiani M.J., Goodman C.S., “Guidance of neuronal growth cones:
selective fasciculation in the grasshopper embryos”, Cold Sping Harb. Symp.
Quant. Biol., 2:587-598, 1983
- Steinman L., “A few autoreactive cells in an autoimmune infiltrate control
a vast population of nonspecifica cells: a tale of smart bombs and the infantry”,
Proc. Natl. Acad. Sci. USA, 93:2253-2256, 1996
- Suter D.M., Pollerberg G.E., Buchstaller A., Giger R.J., Dreyer W.J., Sonderegger
P., “Binding between the neural cell adhesion molecules axonin-1 and NrCAM/Bravo
is involved in neuron-glia interaction” , J.Cell.Biol., 131:1067-1081, 1995
- Takeshida S., Kikuno R., Tezuka K., Amann E. “Osteoblast-specific factor
2: cloning of a putative bone adhesion protein with homology with the insect
protein fasciclin I”, Biochem. 294:271-278, 1993
- The Miami Project to Cure Paralysis, “Cellular Bridges on the Road to Regeneration”
Spring, Vol. IX, N1, 1996
- The Miami Project to Cure Paralysis, “Neural Stem Cells in Spinal Cord Repair”
Research Reviews, 2001 - Toma J.G., Akhavan M., Fernandes K.J.L., Bernabè-Heider
F., Sadikot A., Kaplan D.R., Miller F.D. “Isolation of multipotent adult stem
cells from the dermis of mammalian skin”, Nature Cell Biology, 3, 9:771:777,
2001 - Waxman, S. G.“Demyelination in spinal cord injury and multiple sclerosis:
What can we do to enhance functional recovery?” Journal of Neurotrauma, 9:S105-S117,
1992. - Waxman, S.G.,Demyelinating diseases: New pathological insights, new
therapeutic targets. New England Journal of Medicine, 338:323-325, 1998.
- Waxman, S. G., Kocsis, J. D, “Experimental approaches to restoration of
function of ascending and descending axons in spinal cord injury”. The Neurobiology
of Spinal Cord Injury, R.G. Kalb and S. M. Strittmatter, Eds., Humana Press,
pp. 215-240, 2000
- Wolinsky JS, Narayana PA, Johnson KP. “United States open-label glatiramer
acetate extension trial for relapsing multiple sclerosis: MRI and clinical
correlates. Multiple Sclerosis Study Group and the MRI Analysis Center”Mult
Scler. 7(1):33-41, 2001.